Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C

American Journal of Gastroenterology

Volumn 97, Issue 9, 2002, Pages 2432-2440

  Kumar, K Shiva ^b   Russo, Mark W ^b   Borczuk, Alain C ^b   Brown, Melissa ^b   Esposito, Stephen P ^b   Lobritto, Steven J ^b   Jacobson, Ira M ^b   Brown Jr , Robert S ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; REBETRON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; STEROID;

ADULT; ARTICLE; BRONCHIOLITIS; CASE REPORT; CLINICAL TRIAL; DISEASE PREDISPOSITION; FEMALE; HEPATITIS C; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG TOXICITY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036734462     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04356-3     Document Type: Article

References (31)

1. Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature
2. Alpha-interferon induced severe pneumonitis
3. Interferon alfa associated retinopathy
4. Acute pancreatitis attributed to the use of interferon alfa-2b
5. Side effects of alpha interferon in chronic hepatitis C
6. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C
7. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis
8. Severe exacerbation of asthma: A new side-effect of interferon alpha in patients with asthma and chronic hepatitis C
9. A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration
10. Pleural effusion during interferon treatment for chronic hepatitis C
11. Interstitial pneumonitis and interferon-alfa
12. Recurrence of sarcoidosis following interferon-alpha therapy for chronic hepatitis C
13. Sarcoidosis after interferon therapy for chronic active hepatitis C
14. Interferon related bronchiolitis obliterans organizing pneumonia
15. Organizing pneumonia. Features and prognosis of cryptogenic, secondary and focal variants
16. Therapy of hepatitis C
17. Peginterferon alfa-2a in patients with chronic hepatitis C
18. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
19. Sarcoidosis associated with interferon alpha therapy for chronic hepatitis C
20. Sarcoidosis and IFN-alpha treatment
21. Bronchiolitis obliterans organizing pneumonia
22. Bronchiolitis obliterans organizing pneumonia: Definition and clinical features
23. Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine
24. Cryptogenic organizing pneumonia
25. Idiopathic bronchiolitis obliterans organizing pneumonia: An acute and life-threatening syndrome
26. Bronchoalveolar lavage cell findings in patients with BOOP and related diseases
27. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C
28. A perspective on the clinical effectiveness and tolerance of interferon alpha
29. Side-effects of high dose interferon therapy for chronic hepatitis C
30. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
31. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial